Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Eton Pharmaceuticals (ETON) Return on Sales (2019 - 2025)

Eton Pharmaceuticals' Return on Sales history spans 7 years, with the latest figure at 0.0% for Q4 2025.

  • On a quarterly basis, Return on Sales changed 0.0% to 0.0% in Q4 2025 year-over-year; TTM through Dec 2025 was 0.0%, a 0.0% change, with the full-year FY2025 number at 0.0%, changed 0.0% from a year prior.
  • Return on Sales hit 0.0% in Q4 2025 for Eton Pharmaceuticals, up from 0.0% in the prior quarter.
  • Over the last five years, Return on Sales for ETON hit a ceiling of 0.0% in Q1 2021 and a floor of 0.08% in Q3 2021.
  • Historically, Return on Sales has averaged 0.01% across 5 years, with a median of 0.0% in 2025.
  • The widest YoY moves for Return on Sales: up 236bps in 2021, down -2562bps in 2021.
  • Tracing ETON's Return on Sales over 5 years: stood at 0.0% in 2021, then plummeted by -37bps to 0.0% in 2022, then crashed by -171bps to 0.0% in 2023, then soared by 32bps to 0.0% in 2024, then surged by 236bps to 0.0% in 2025.
  • Business Quant data shows Return on Sales for ETON at 0.0% in Q4 2025, 0.0% in Q3 2025, and 0.0% in Q2 2025.